|
US3003097A
(en)
|
1958-07-17 |
1961-10-03 |
Gen Electric |
Sequence control system for timing motor
|
|
JP3101690B2
(ja)
|
1987-03-18 |
2000-10-23 |
エス・ビィ・２・インコーポレイテッド |
変性抗体の、または変性抗体に関する改良
|
|
DK1621554T4
(da)
|
1992-08-21 |
2012-12-17 |
Univ Bruxelles |
Immunoglobuliner blottet for lette kæder
|
|
US5834597A
(en)
|
1996-05-20 |
1998-11-10 |
Protein Design Labs, Inc. |
Mutated nonactivating IgG2 domains and anti CD3 antibodies incorporating the same
|
|
US8173127B2
(en)
|
1997-04-09 |
2012-05-08 |
Intellect Neurosciences, Inc. |
Specific antibodies to amyloid beta peptide, pharmaceutical compositions and methods of use thereof
|
|
US6905686B1
(en)
|
1997-12-02 |
2005-06-14 |
Neuralab Limited |
Active immunization for treatment of alzheimer's disease
|
|
US6761888B1
(en)
|
2000-05-26 |
2004-07-13 |
Neuralab Limited |
Passive immunization treatment of Alzheimer's disease
|
|
US7179892B2
(en)
|
2000-12-06 |
2007-02-20 |
Neuralab Limited |
Humanized antibodies that recognize beta amyloid peptide
|
|
US7964192B1
(en)
|
1997-12-02 |
2011-06-21 |
Janssen Alzheimer Immunotherapy |
Prevention and treatment of amyloidgenic disease
|
|
US6750324B1
(en)
|
1997-12-02 |
2004-06-15 |
Neuralab Limited |
Humanized and chimeric N-terminal amyloid beta-antibodies
|
|
US6518011B1
(en)
|
1999-01-13 |
2003-02-11 |
Bristol-Myers Squibb Company |
Method for screening compounds to identify beta-amyloid production modulators
|
|
NZ513144A
(en)
|
1999-02-05 |
2003-05-30 |
Samsung Electronics Co Ltd |
Image texture retrieving method and apparatus thereof
|
|
US7629311B2
(en)
|
1999-02-24 |
2009-12-08 |
Edward Lewis Tobinick |
Methods to facilitate transmission of large molecules across the blood-brain, blood-eye, and blood-nerve barriers
|
|
US6787637B1
(en)
|
1999-05-28 |
2004-09-07 |
Neuralab Limited |
N-Terminal amyloid-β antibodies
|
|
DE1257584T1
(de)
|
2000-02-24 |
2003-05-28 |
Lilly Co Eli |
Humanisierte antikörper, die amyloid beta peptid demarkieren
|
|
PE20020574A1
(es)
|
2000-12-06 |
2002-07-02 |
Wyeth Corp |
Anticuerpos humanizados que reconocen el peptido amiloideo beta
|
|
US7700751B2
(en)
|
2000-12-06 |
2010-04-20 |
Janssen Alzheimer Immunotherapy |
Humanized antibodies that recognize β-amyloid peptide
|
|
EP2165714B1
(en)
|
2001-04-30 |
2013-10-23 |
Eli Lilly And Company |
Humanized antibodies recognizing the beta-amyloid peptide
|
|
MY139983A
(en)
|
2002-03-12 |
2009-11-30 |
Janssen Alzheimer Immunotherap |
Humanized antibodies that recognize beta amyloid peptide
|
|
WO2004029629A1
(en)
|
2002-09-27 |
2004-04-08 |
Janssen Pharmaceutica N.V. |
N-11 truncated amyloid-beta nomoclonal antibodies, compositions, methods and uses
|
|
EA200501524A1
(ru)
|
2003-03-28 |
2006-06-30 |
Сентокор, Инк. |
Антитела против амилоида, композиции, способы и применения
|
|
TWI306458B
(en)
|
2003-05-30 |
2009-02-21 |
Elan Pharma Int Ltd |
Humanized antibodies that recognize beta amyloid peptide
|
|
EP2434420A3
(en)
|
2003-08-01 |
2012-07-25 |
Dna Twopointo Inc. |
Systems and methods for biopolymer engineering
|
|
US8005620B2
(en)
|
2003-08-01 |
2011-08-23 |
Dna Twopointo Inc. |
Systems and methods for biopolymer engineering
|
|
WO2005018424A2
(en)
|
2003-08-18 |
2005-03-03 |
Research Foundation For Mental Hygiene, Inc. |
Antibodies specific for fibrillar amyloid and a procedure to detect fibrillar amyloid deposits
|
|
SE0401601D0
(sv)
|
2004-06-21 |
2004-06-21 |
Bioarctic Neuroscience Ab |
Protofibril specific antibodies and uses thereof
|
|
MX2007000998A
(es)
|
2004-07-30 |
2007-07-11 |
Rinat Neuroscience Corp |
Anticuerpos dirigidos peptido beta-amiloide y procedimientos que usan los mismos.
|
|
US7335491B2
(en)
|
2004-08-27 |
2008-02-26 |
Wyeth Research Ireland Limited |
Production of anti-abeta
|
|
AU2005294131A1
(en)
|
2004-10-05 |
2006-04-20 |
Wyeth |
Methods and compositions for improving recombinant protein production
|
|
WO2006040153A2
(en)
|
2004-10-13 |
2006-04-20 |
Ablynx N.V. |
Single domain camelide anti -amyloid beta antibodies and polypeptides comprising the same for the treatment and diagnosis of degenarative neural diseases such as alzheimer's disease
|
|
CA2589017A1
(en)
|
2004-12-15 |
2006-06-22 |
Neuralab Limited |
Amyloid beta antibodies for use in improving cognition
|
|
GT200600031A
(es)
|
2005-01-28 |
2006-08-29 |
|
Formulacion anticuerpo anti a beta
|
|
ZA200710330B
(en)
|
2005-06-17 |
2009-12-30 |
Wyeth Corp |
Methods of purifying FC region containing proteins
|
|
US8691224B2
(en)
|
2005-11-30 |
2014-04-08 |
Abbvie Inc. |
Anti-Aβ globulomer 5F7 antibodies
|
|
MY155286A
(en)
|
2005-12-12 |
2015-09-30 |
Hoffmann La Roche |
Antibodies against amyloid beta 4 with glycosylated in the variable region
|
|
JP5103466B2
(ja)
|
2006-03-30 |
2012-12-19 |
グラクソ グループ リミテッド |
アミロイド‐βペプチドに対する抗体
|
|
US8784810B2
(en)
|
2006-04-18 |
2014-07-22 |
Janssen Alzheimer Immunotherapy |
Treatment of amyloidogenic diseases
|
|
EP2046833B9
(en)
|
2006-07-14 |
2014-02-19 |
AC Immune S.A. |
Humanized antibody against amyloid beta
|
|
WO2008030251A1
(en)
|
2006-09-08 |
2008-03-13 |
Georgetown University |
Deglycosylated anti-amyloid beta antibodies
|
|
SI2074145T1
(sl)
|
2006-10-02 |
2017-12-29 |
Ac Immune S.A. |
Humanizirano protitelo proti amiloid beta
|
|
WO2008081008A1
(en)
|
2007-01-05 |
2008-07-10 |
University Of Zurich |
Method of providing disease-specific binding molecules and targets
|
|
HRP20140049T1
(hr)
|
2007-01-05 |
2014-02-28 |
University Of Zürich |
Anti beta-amiloid antitijela i njihova upotreba
|
|
US20080292625A1
(en)
|
2007-04-18 |
2008-11-27 |
Sally Schroeter |
Prevention and treatment of cerebral amyloid angiopathy
|
|
US8003097B2
(en)
|
2007-04-18 |
2011-08-23 |
Janssen Alzheimer Immunotherapy |
Treatment of cerebral amyloid angiopathy
|
|
ES2529174T3
(es)
|
2007-06-12 |
2015-02-17 |
Ac Immune S.A. |
Anticuerpos humanizados para amiloide beta
|
|
DK2182983T3
(da)
|
2007-07-27 |
2014-07-14 |
Janssen Alzheimer Immunotherap |
Behandling af amyloidogene sygdomme med humaniserede anti-abeta antistoffer
|
|
BRPI0818623A2
(pt)
|
2007-10-05 |
2017-05-23 |
Ac Immune Sa |
composição farmacêutica, e, métodos para reduzir a carga da placa na camada de célula de gânglio retinal de um animal, para reduzir a quantidade de placas na camada de célula de gânglio retinal de um animal, para diminuir a quantidade total de amilóide-beta solúvel na camada de célula de gânglio retinal de um animal, para prevenir, tratar e/ou aliviar os efeitos de uma doença ocular associada com anormalidades patológicas/mudanças no tecido do sistema visual, para monitorar doença ocular residual mínima associada com anormalidades patológicas/mudanças nos tecidos do sistema visual, para predizer responsividade de um paciente, e para reter ou diminuir a pressão ocular nos olhos de um animal
|
|
JO3076B1
(ar)
|
2007-10-17 |
2017-03-15 |
Janssen Alzheimer Immunotherap |
نظم العلاج المناعي المعتمد على حالة apoe
|
|
US20100291071A1
(en)
|
2008-08-01 |
2010-11-18 |
Immunas Pharma, Inc. |
Antibody Specific Binding to A-Beta Oligomer and the Use
|
|
CN101965365A
(zh)
|
2007-10-19 |
2011-02-02 |
伊缪纳斯制药株式会社 |
能够特异性结合Aβ寡聚体的抗体及其应用
|
|
EP2207568B1
(en)
|
2007-11-16 |
2017-05-31 |
The Rockefeller University |
Antibodies specific for the protofibril form of beta-amyloid protein
|
|
CN102936287B
(zh)
|
2008-02-08 |
2015-09-09 |
伊缪纳斯制药株式会社 |
能够特异性结合Aβ寡聚体的抗体及其应用
|
|
TW201006485A
(en)
|
2008-06-03 |
2010-02-16 |
Abbott Lab |
Dual variable domain immunoglobulins and uses thereof
|
|
US7561973B1
(en)
|
2008-07-31 |
2009-07-14 |
Dna Twopointo, Inc. |
Methods for determining properties that affect an expression property value of polynucleotides in an expression system
|
|
US8126653B2
(en)
|
2008-07-31 |
2012-02-28 |
Dna Twopointo, Inc. |
Synthetic nucleic acids for expression of encoded proteins
|
|
CN102149825B
(zh)
|
2008-07-08 |
2015-07-22 |
Abbvie公司 |
前列腺素e2双重可变结构域免疫球蛋白及其用途
|
|
EP2321348A2
(en)
|
2008-07-09 |
2011-05-18 |
University of Zürich |
Method of promoting neurogenesis
|
|
WO2010030203A1
(en)
|
2008-09-09 |
2010-03-18 |
Biocodex - Incubação De Empresas De Ciências Da Vida, S.A. |
Monoclonal antibody to human amyloidogenic and modified forms of transthyretin and its use in the detection and treatment of fap and pathologies presenting modified ttr
|
|
US9067981B1
(en)
|
2008-10-30 |
2015-06-30 |
Janssen Sciences Ireland Uc |
Hybrid amyloid-beta antibodies
|
|
CN102459335B
(zh)
|
2009-04-17 |
2015-11-25 |
伊缪纳斯制药株式会社 |
特异性结合Aβ寡聚体的抗体及其用途
|
|
US8512677B2
(en)
|
2009-04-27 |
2013-08-20 |
Case Western Reserve University |
Pyro-glutamate Aβ targeting agents
|
|
US20110008766A1
(en)
|
2009-05-01 |
2011-01-13 |
Abbott Laboratories |
Dual Variable Domain Immunoglobulins and Uses Thereof
|
|
RU2012103240A
(ru)
|
2009-07-02 |
2013-08-10 |
Ангиокем Инк. |
Мультимерные пептидные конъюгаты и их применение
|
|
WO2011016238A1
(en)
|
2009-08-06 |
2011-02-10 |
Immunas Pharma, Inc. |
Antibodies that specifically bind to a beta oligomers and use thereof
|
|
WO2011031720A1
(en)
|
2009-09-11 |
2011-03-17 |
Arizona Board Of Regents Acting For And On Behalf Of Arizona State University |
Bispecific nanobodies as a therapeutic for alzheimer's disease
|
|
NZ601117A
(en)
|
2010-03-03 |
2014-06-27 |
Boehringer Ingelheim Int |
Biparatopic abeta binding polypeptides
|
|
US8987419B2
(en)
|
2010-04-15 |
2015-03-24 |
AbbVie Deutschland GmbH & Co. KG |
Amyloid-beta binding proteins
|
|
US9320793B2
(en)
|
2010-07-14 |
2016-04-26 |
Acumen Pharmaceuticals, Inc. |
Method for treating a disease associated with soluble, oligomeric species of amyloid beta 1-42
|
|
EP2598882B1
(en)
|
2010-07-30 |
2017-07-26 |
AC Immune S.A. |
Safe and functional humanized antibodies for use in treating an amyloidosis
|
|
PL3042917T3
(pl)
|
2010-08-12 |
2018-07-31 |
Eli Lilly And Company |
Przeciwciała przeciwko peptydowi beta amyloidu N3pGlu i ich zastosowanie
|
|
WO2012021475A2
(en)
|
2010-08-12 |
2012-02-16 |
Eli Lilly And Company |
ANTI-N3pGlu AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOF
|
|
US9499610B2
(en)
|
2011-04-08 |
2016-11-22 |
H. Lundbeck A/S |
Antibodies specific to pyroglutamated Aβ
|
|
US9534016B2
(en)
|
2011-11-28 |
2017-01-03 |
Buck Institute For Research On Aging |
Netrin loop peptide mimetics and uses thereof
|
|
DK2807188T3
(da)
*
|
2012-01-27 |
2019-10-07 |
Prothena Biosciences Ltd |
Humaniserede antistoffer, der genkender alpha-synuclein
|
|
ITRM20120383A1
(it)
|
2012-03-20 |
2013-09-21 |
Uni Degli Studi Di Milano B Icocca |
Metodo e kit per la rivelazione di anticorpi.
|
|
JP2015526409A
(ja)
|
2012-07-03 |
2015-09-10 |
ヤンセン・サイエンシズ・アイルランド・ユーシー |
Ｃ−末端及び中心エピトープａ−ベータ抗体
|
|
US20150315267A1
(en)
|
2012-12-07 |
2015-11-05 |
Thierry Bussiere |
A method of reducing brain amyloid plaques using anti-ab antibodies
|
|
US20140314741A1
(en)
|
2013-04-18 |
2014-10-23 |
Developmen Center For Biotechnology |
Human Antibody against Interleukin-20 and Treatment for Inflammatory Diseases
|
|
US9486559B2
(en)
|
2013-05-07 |
2016-11-08 |
Abbott Cardiovascular Systems Inc. |
Methods of treatment with a bioresorbable scaffold for neurologic drug delivery
|
|
US10513555B2
(en)
|
2013-07-04 |
2019-12-24 |
Prothena Biosciences Limited |
Antibody formulations and methods
|
|
WO2015035190A1
(en)
|
2013-09-05 |
2015-03-12 |
Cornell University |
Gene therapy for alzheimer's and other neurodegenerative diseases and conditions
|
|
KR20250057056A
(ko)
|
2013-12-20 |
2025-04-28 |
뉴리뮨 홀딩 아게 |
트랜스티레틴(ttr) 아밀로이드증의 항체-기반의 치료 및 이를 위한 인간-유래의 항체
|
|
EP3102230B1
(en)
|
2014-02-08 |
2021-04-28 |
F. Hoffmann-La Roche AG |
Methods of treating alzheimer's disease
|
|
CA2944402A1
(en)
|
2014-04-08 |
2015-10-15 |
Prothena Biosciences Limited |
Blood-brain barrier shuttles containing antibodies recognizing alpha-synuclein
|
|
WO2015165961A1
(en)
|
2014-04-29 |
2015-11-05 |
Affiris Ag |
Treatment and prevention of alzheimer's disease (ad)
|
|
US20170152306A1
(en)
|
2014-05-16 |
2017-06-01 |
Universitat Autonoma De Barcelona |
Single chain variable fragment (scfv) elongation mutants
|
|
WO2015191934A2
(en)
|
2014-06-11 |
2015-12-17 |
Abbvie Inc. |
Blood-brain barrier (bbb) penetrating dual specific binding proteins for treating brain and neurological diseases
|
|
WO2016005466A2
(en)
|
2014-07-10 |
2016-01-14 |
Bioarctic Neuroscience Ab |
IMPROVED Aß PROTOFIBRIL BINDING ANTIBODIES
|
|
CA2954738A1
(en)
|
2014-07-29 |
2016-02-04 |
Neurimmune Holding Ag |
Human-derived anti-huntingtin (htt) antibodies and uses thereof
|
|
WO2016040903A1
(en)
|
2014-09-11 |
2016-03-17 |
Board Of Regents Of The University Of Texas System |
Detection of misfolded amyloid beta protein
|
|
MA41115A
(fr)
|
2014-12-02 |
2017-10-10 |
Biogen Int Neuroscience Gmbh |
Procédé de traitement de la maladie d'alzheimer
|
|
JP2018501482A
(ja)
|
2014-12-19 |
2018-01-18 |
プロビオドルグ エージー |
ｐＧｌｕ−Ａｂｅｔａペプチドの検出のための新規の方法
|
|
EP3262070A4
(en)
|
2015-02-24 |
2018-07-25 |
Rpeptide, LLC |
Anti-amyloid-beta antibodies
|
|
CA2992386A1
(en)
|
2015-07-16 |
2017-01-19 |
Probiodrug Ag |
Humanized antibodies
|
|
CR20180365A
(es)
|
2015-12-16 |
2018-09-28 |
Amgen Inc |
PROTEÍNAS DE UNIÓN AL ANTÍGENO BISPECÍFICO DE ANTI-TL1A/ANTI-TNF-a Y SUS USOS
|
|
JOP20170004B1
(ar)
|
2016-01-15 |
2022-09-15 |
Lilly Co Eli |
الأجسام المضادة لببتيد بيتا النشوي مضاد N3pGlu واستخداماته
|
|
US20190016791A1
(en)
|
2016-01-20 |
2019-01-17 |
Genentech, Inc. |
High dose treatments for alzheimer's disease
|
|
EP4063858A1
(en)
|
2016-03-14 |
2022-09-28 |
Biogen International Neuroscience GmbH |
Antibody-dependent cell-mediated phagocytosis assay for reliably measuring uptake of aggregated proteins
|
|
EP3448427A1
(en)
|
2016-04-29 |
2019-03-06 |
CureVac AG |
Rna encoding an antibody
|
|
CN114796481A
(zh)
|
2016-06-07 |
2022-07-29 |
生物基因国际神经科学有限责任公司 |
治疗阿尔茨海默病的方法
|
|
SG11201900123TA
(en)
|
2016-07-19 |
2019-02-27 |
Annexon Inc |
Compositions and methods for treating frontotemporal dementia
|
|
BR112019008359A2
(pt)
|
2016-10-27 |
2019-10-01 |
Eisai R&D Man Co Ltd |
método para tratamento da doença de alzheimer, e, composição farmacêutica.
|
|
TW201827467A
(zh)
|
2016-11-03 |
2018-08-01 |
比利時商健生藥品公司 |
焦穀胺酸類澱粉蛋白－β之抗體及其用途
|
|
BR112018014281A2
(pt)
|
2016-11-15 |
2018-12-18 |
H Lundbeck As |
agentes, usos e métodos para o tratamento da sinucleinopatia
|
|
US20200188528A1
(en)
|
2016-12-19 |
2020-06-18 |
Fred Hutchinson Cancer Research Center |
Peptide-antibody compositions and methods of use thereof
|
|
EP3354278A1
(en)
|
2017-01-31 |
2018-08-01 |
Sanofi |
Neuronal cell protective effect of antibodies specific for the protofibrillar form of the beta-amyloid peptide
|
|
WO2018204408A1
(en)
|
2017-05-02 |
2018-11-08 |
Sanford Burnham Prebys Medical Discovery Institute |
Methods of diagnosing and treating alzheimer's disease
|
|
EP3431496A1
(en)
|
2017-07-19 |
2019-01-23 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Anti- isoasp7 amyloid beta antibodies and uses thereof
|
|
CN118370815A
(zh)
|
2017-08-22 |
2024-07-23 |
渤健马萨诸塞州股份有限公司 |
含有抗β淀粉样蛋白抗体的药物组合物
|
|
US20190153102A1
(en)
|
2017-09-28 |
2019-05-23 |
Prothena Biosciences Limited |
Dosing regimes for treatment of synucleinopathies
|
|
WO2019064053A1
(en)
|
2017-09-28 |
2019-04-04 |
Prothena Biosciences Limited |
DOSAGE REGIMES FOR THE TREATMENT OF SYNUCLEINOPATHIES
|
|
US20200330592A1
(en)
|
2017-10-09 |
2020-10-22 |
Keith Black |
Compositions and methods of treating alzheimer's and other amyloid related diseases
|
|
JP7387613B2
(ja)
|
2018-02-09 |
2023-11-28 |
ザ トラスティーズ オブ ダートマス カレッジ |
神経変性疾患及び障害の治療のためのキメラ抗原受容体
|
|
CN111094340B
(zh)
|
2018-07-17 |
2022-11-22 |
江苏恒瑞医药股份有限公司 |
抗Abeta抗体、其抗原结合片段及应用
|
|
US20210324056A1
(en)
|
2018-07-24 |
2021-10-21 |
Eisai R&D Management Co., Ltd. |
Methods of treatment and prevention of alzheimer's disease
|
|
CN121248772A
(zh)
|
2018-08-17 |
2026-01-02 |
Ab工作室有限公司 |
催化抗体和其使用方法
|
|
JP7499760B2
(ja)
|
2018-11-02 |
2024-06-14 |
アネクソン，インコーポレーテッド |
脳損傷を治療するための組成物及び方法
|
|
JP2022520572A
(ja)
|
2019-02-12 |
2022-03-31 |
プロシーナ バイオサイエンシーズ リミテッド |
免疫グロブリン軽鎖に対するモノクローナル抗体と、抗体産生細胞および他の免疫細胞上のｃｄ３８細胞膜分子に対するモノクローナル抗体の組み合わせによるａｌアミロイドーシスの処置
|
|
JOP20210265A1
(ar)
|
2019-03-26 |
2023-01-30 |
Janssen Pharmaceutica Nv |
الأجسام المضادة لبيروغلوتامات أميلويد بيتا واستخداماتها
|
|
WO2020198866A1
(en)
|
2019-04-04 |
2020-10-08 |
The Royal Institution For The Advancement Of Learning / Mcgill University |
USE OF Aß34 TO ASSESS ALZHEIMER'S DISEASE PROGRESSION
|
|
JP2022544640A
(ja)
|
2019-06-21 |
2022-10-20 |
ユニバーシティ オブ カンザス |
脳疾患の治療に有用な組成物および方法
|
|
ES2821599A1
(es)
|
2019-10-24 |
2021-04-26 |
Univ Del Pais Vasco / Euskal Herriko Unibertsitatea |
Compuestos y metodos para el tratamiento de la enfermedad de alzheimer
|
|
AU2020401837A1
(en)
|
2019-12-11 |
2022-07-21 |
Ambetex Pty Ltd |
Therapeutic compositions comprising an amyloid beta antibody or vaccine for prevention and treatment of diastolic dysfunction
|
|
RS67249B1
(sr)
|
2020-03-20 |
2025-10-31 |
Eisai R&D Man Co Ltd |
Formulacije antitela visoke koncentracije protiv protofibrila amiloid beta peptida i metode njihove upotrebe
|
|
KR20230039734A
(ko)
|
2020-07-23 |
2023-03-21 |
오타이르 프로테나 리미티드 |
항-Aβ 항체
|